Heart failure trials in Germany
111 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleIntrahospital Influenza Vaccination in Patients at High Cardiovascular Risk (VACC-UP)
- Where
- Cologne, Hamburg
- Age
- 18 years and over
- People
- 482
- Run by
- Stephan Baldus
See details and how to joinNCT07721649 - No phaseTaking peopleA Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting
- Where
- Multiple Locations
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- Bayer
See details and how to joinNCT07235462 - Phase 2Taking peopleA Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
- Where
- Berlin, Dresden, Essen, Frankfurt Am Main, Halle Saale, Hanover, Heidelberg, Kiel
- Age
- 40 years to 84 years
- People
- 200 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06979362 · EU 2024-515796-35-00 - No phaseNot yet taking people in GermanyRemote Monitoring and Optimization of Heart Failure Therapy
- Where
- Giessen
- Age
- 18 years to 85 years
- People
- 800 worldwide
- Run by
- Zoll Medical Corporation
See details and how to joinNCT07622472 - No phaseTaking peopleEarly Feasibility Study of the Edwards APTURE Transcatheter Shunt System
- Where
- Cologne, Dresden, Mainz
- Age
- 18 years and over
- People
- 15
- Run by
- Edwards Lifesciences
See details and how to joinNCT07858799 - Phase 3Taking peopleA Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Where
- Bad Oldesloe, Bamberg, Berlin, Bielefeld, Bremen, Chemnitz, Cologne, Dresden, Elsterwerda, Erlangen, Essen, Freiburg im Breisgau, Gera, Hamburg, Heidelberg, Homburg, Jena, Kaiserslautern, Karlsbad, Kiel, Ludwigshafen, Ludwigshafen Am Rhein, Lüneburg, Magdeburg, Mainz, Markkleeberg, Mühldorf am Inn, Neuruppin, Nürnberg, Obertshausen, Paderborn, Papenburg, Stuttgart, Trier, Tuebingen, Ulm
- Age
- 18 years and over
- People
- 6,950 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07761117 · EU 2026-526304-79-00 - Phase 2Taking peopleImpact of Glucagon on Physical Capacity and Metabolism
- Where
- Bochum
- Age
- 18 years and over
- People
- 33
- Run by
- Katholisches Klinikum Bochum gGmbH
See details and how to join2025-521835-35-00 · EU 2025-521835-35-00 - No phaseTaking peopleLeft Bundle Branch Area Pacing (LBBAP) PMCF Study
- Where
- Bad Nauheim
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- Abbott Medical Devices
See details and how to joinNCT07217392 - No phaseNot yet taking people in GermanyA Comparison of Left Bundle Branch Optimized Cardiac Resynchronization Therapy vs Left Bundle Branch Area Pacing Alone
- Where
- Neuruppin
- Age
- 18 years and over
- People
- 124
- Run by
- PD Dr. Guram Imnadze
See details and how to joinNCT07842874 - No phaseTaking peopleEvaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)
- Where
- Berlin
- Age
- 18 years and over
- People
- 149 worldwide
- Run by
- Echosens
See details and how to joinNCT07222813 - No phaseTaking peopleAlEX-DHF: Ablation and Exercise in Diastolic Heart Failure
- Where
- Munich
- Age
- 18 years to 99 years
- People
- 40
- Run by
- Technical University of Munich
See details and how to joinNCT06650995 - No phaseTaking peopleTezspire Cardiac Events PASS
- Where
- Berlin
- Age
- 12 years to 130 years
- People
- 16,640 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06951867 - Phase 1/2Taking peopleA Phase 1b/2a Trial to Evaluate Invobenitug Also Known as Procizumab (PCZ; AK1967) in Critical Cardiovascular Care.
- Where
- Bad Krozingen, Berlin, Hamburg, Leipzig, Mannheim
- Age
- 18 years to 80 years
- People
- 90 worldwide
- Run by
- 4TEEN4 Pharmaceuticals GmbH
See details and how to joinNCT06832722 · EU 2024-518450-16-00 - Phase 2Not yet taking people in GermanyA Study to Evaluate the Safety and Efficacy of AC01 Compared to Placebo in Participants With Chronic Heart Failure
- Where
- Freiburg im Breisgau, Jena, Magdeburg, Neuwied, Papenburg
- Age
- 18 years to 85 years
- People
- 400 worldwide
- Run by
- AnaCardio AB
See details and how to joinNCT07584967 · EU 2025-524469-25-00 - No phaseTaking peopleBAROSTIM THERAPY™ in Heart Failure With Reduced Ejection Fraction
- Where
- Bad Oeynhausen, Berlin, Bernau, Chemnitz, Cologne, Detmold, Dresden, Frankfurt, Giessen, Göttingen, Hamburg, Hamm, Hanover, Ingolstadt, Kiel, Lahr, Leipzig, Mainz, Münster, Paderborn, Regensburg, Siegen, Stadtlohn, Tuttlingen
- People
- 500 worldwide
- Run by
- CVRx, Inc.
See details and how to joinNCT02880618 - No phaseTaking peoplePacing Advancements With Cost and Experience VALuation for Unified Patient-Led Clinical Evidence - the PACEVALUE Study
- Where
- Bad Krozingen
- Age
- 18 years and over
- People
- 4,500 worldwide
- Run by
- Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT07276139 - Phase 3Taking peopleA Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Where
- Berlin, Dresden, Giessen, Jena, Lübeck, Regensburg
- Age
- 18 years and over
- People
- 5,200 worldwide
- Run by
- Colorado Prevention Center
See details and how to joinNCT06008197 - No phaseTaking peopleRetinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM
- Where
- Berlin, Essen, Frankfurt am Main, Würzburg
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07690436 - Phase 1Taking peopleA STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF COR-1389
- Where
- Neuss
- Age
- 18 years to 64 years
- People
- 140
- Run by
- Corteria Pharmaceuticals
See details and how to join2024-514853-31-00 · EU 2024-514853-31-00 - No phaseTaking peopleA Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Where
- Aalen, Berlin, Bernau, Dresden, Erlangen, Leipzig, Münster
- Age
- 18 years and over
- People
- 1,700 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT05489705 - Phase 3Taking peopleA Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Where
- Aachen, Bad Friedrichshall, Bad Oeynhausen, Berlin, Bochum, Coburg, Cologne, Dresden, Elsterwerda, Erfurt, Essen, Frankfurt Am Main, Freiburg im Breisgau, Hamburg, Kaiserslautern, Kamp-Lintfort, Kiel, Langen (Hesse), Ludwigshafen am Rhein, Mainz, Markkleeberg, Muenster, Neuruppin, Osnabrueck, Papenburg, Rostock, Rotenburg A. D. Fulda, Stuhr, Stuttgart, Traunstein, Wermsdorf, Weyhe-Leeste, Witten, Wuerzburg
- Age
- 18 years and over
- People
- 5,610 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07567001 · EU 2025-523717-29-00 - No phaseTaking peopleAlleviant ALLAY-HF Study
- Where
- Hamburg, Lübeck, Magdeburg
- Age
- 40 years and over
- People
- 700 worldwide
- Run by
- Alleviant Medical, Inc.
See details and how to joinNCT05685303 - No phaseTaking peopleMultimodal Phenotyping In Patients Referred With Acute Cardiac faiLurE
- Where
- Bad Krozingen, Freiburg im Breisgau, Nuremberg, Villingen-Schwenningen
- Age
- 18 years and over
- People
- 600
- Run by
- University Heart Center Freiburg - Bad Krozingen
See details and how to joinNCT07515508 - No phaseTaking peopleEarly Detection and IntervenTion in Heart Failure
- Where
- Freiburg im Breisgau, Herne, Leipzig
- Age
- 65 years and over
- People
- 18,000 worldwide
- Run by
- University Hospital, Basel, Switzerland
See details and how to joinNCT07731490 - Phase 3Taking peopleStudy to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
- Where
- Frankfurt am Main
- Age
- 2 years to 11 years
- People
- 9 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597006